More Ways to Connect
  LinkedIn Twitter YouTube Instagram
Nelson Watts, MD, explains to a patient how osteoporosis develops.
UC's Amit Bhattacharya, PhD, and Nelson Watts, MD, have developed a tool for testing the risk for fracture in people with osteoporosis. Bhattacharya explains the innovative technology.

Nelson Watts, MD, explains to a patient how osteoporosis develops.

Amit Bhattacharya, PhD, is trying to determine if a new, noninvasive screening technique can effectively predict—even prevent—bone fractures in postmenopausal women with osteoporosis
Back Next
Publish Date: 03/17/10
Media Contact: AHC Public Relations, (513) 558-4553
PDF download
RSS feed
related news
share this
'Bone Shock Absorbance' Technology Is Impetus Behind New Company

CINCINNATI—A technology developed by two UC professors is the impetus behind the new company OsteoDynamics, Inc.

The life-science company, founded by UC’s Amit Bhattacharya, PhD, and Nelson Watts, MD, and formed with the help of Integrated BioScience Solutions, LLC, (IGBS) and the business incubator BIOSTART, will develop a new diagnostic tool to test a patient’s risk of bone fracture based on the concept of "Bone Shock Absorbance.”

The company will be based out of BIOSTART and David Ralph of IGBS will serve as the chief executive officer.

Bone Shock Absorbance is a non-invasive and painless test that measures how the energy associated with simple heel strike by a patient is propagated, absorbed and dissipated as its shock wave moves up a patient’s skeleton. The test provides information that measures a patient’s bone quality and appears to be a better indicator of fracture risk than the commonly used methods that simply measures the mineral density of a patient’s bones.

On Feb. 3, 2010, OsteoDynamics signed an option agreement to license the Bone Shock Absorbance technology and its associated know-how from the university. The company also received $125,000 of seed financing from Southern Ohio Creates Companies (SOCC) on March 8, 2010. 

"Osteoporosis is a terrible disease afflicting ten million patients in the United States, resulting in approximately two million bone fractures each year and enormous health care costs,” says Watts, professor of medicine and director of the Bone Health and Osteoporosis Center at UC. "Our Bone Shock Absorbance technology has the potential to more accurately identify patients who will suffer an osteoporosis-related bone fracture than is currently possible with alternative diagnostic techniques.”

"The key to reducing the number of osteoporosis-related fractures and their associated health care costs is the availability of a diagnostic test that can better determine which patients are most likely to suffer these types of fractures,” says Bhattacharya, a professor in the department of environmental health. "With that information, we can then provide them with more effective medications and other interventions that have already been proven to reduce fracture risk. Initial clinical data indicates that Bone Shock Absorbance may be the diagnostic technology that can achieve this goal.”


 back to list | back to top